Consensus Protalix BioTherapeutics, Inc.

Equities

PLX

US74365A3095

Market Closed - Nyse 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
1.26 USD +0.80% Intraday chart for Protalix BioTherapeutics, Inc. -4.55% -29.21%

Evolution of the average Target Price on Protalix BioTherapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

bbfb0b.xSrZF8lLUTxGMq2O3nHnXylE5vyJha2twqs-zNOTT-E.i2Lvcp4hZlcPfZzvjj6WNmg8opHT7d_ukMdR_aXdH4-kH4F98SEkbi54_A~d85675e25f09936fd43e9cc1b60c6e94

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.26 USD
Average target price
13 USD
Spread / Average Target
+931.75%
High Price Target
16 USD
Spread / Highest target
+1,169.84%
Low Price Target
10 USD
Spread / Lowest Target
+693.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Protalix BioTherapeutics, Inc.

HC Wainwright
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
  1. Stock
  2. Equities
  3. Stock Protalix BioTherapeutics, Inc. - Nyse
  4. Consensus Protalix BioTherapeutics, Inc.